DOCSLIB.ORG

RNA Expression of Cytochrome P450 in Mexican Women with Breast Cancer

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
RNA Expression of Cytochrome P450 in Mexican Women with Breast Cancer DOI:http://dx.doi.org/10.7314/APJCP.2012.13.6.2647 RNA Expression of Cytochrome P450 in Mexican Women with Breast Cancer RESEARCH COMMUNICATION RNA Expression of Cytochrome P450 in Mexican Women with Breast Cancer Cindy Bandala1, E Floriano-Sánchez1,2*, N Cárdenas-Rodríguez1,3, J López- Cruz4, E Lara-Padilla1 Abstract Involvement of cytochrome P450 genes (CYPs) in breast cancer (BCa) may differ between populations, with expression patterns affected by tumorigenesis. This may have an important role in the metabolism of anticancer drugs and in the progression of cancer. The aim of this study was to determine the mRNA expression patterns of four cytochrome P450 genes (CYP2W1, 3A5, 4F11 and 8A1) in Mexican women with breast cancer. Real- time PCR analyses were conducted on 32 sets of human breast tumors and adjacent non-tumor tissues, as well as 20 normal breast tissues. Expression levels were tested for association with clinical and pathological data of patients. We found higher gene expression of CYP2W1, CYP3A5, CYP4F11 in BCa than in adjacent tissues and only low in normal mammary glands in our Mexican population while CYP8A1 was only expressed in BCa and adjacent tissues. We found that Ki67 protein expression was associated with clinicopathological features as well as with CYP2W1, CYP4F11 and CYP8A1 but not with CYP3A5. The results indicated that breast cancer tissues may be better able to metabolize carcinogens and other xenobiotics to active species than normal or adjacent non-tumor tissues. Keywords: CYP2W1 - CYP3A5 - CYP4F11 - CYP8A1 - mRNA - breast cancer Asian Pacific J Cancer Prev, 13, 2647-2653 Introduction Thus, it is important to determine the expression patterns in different populations. Breast cancer (BCa) is the most common malignant Cytochrome P450 2W1 (CYP2W1) has been shown tumor in the 25 years and over Mexican female population to participate in the oxidation of arachidonic acid and with an increase of 30% of cancer-related deaths in the last catalysts the reductive activation of AQ4N to AQ4 (an 20 years (WHO, 2008; SINAIS, 2010). The expression anticancer drug) and in the bioactivation of several pro- of tumors specific proteins in mammary glands may play carcinogens including polycyclic aromatic hydrocarbons a critical role in the development of BCa as well as in the and aflatoxin B1 (Wu et al., 2006; Nishida et al., 2010). success of chemotherapy treatment. To date, very few mRNA expression was detected in tumor tissues from critical markers have been validated for the prediction of colon, adrenal, and lung, while no expression was seen drug efficiency in BCa (Vaclavikova et al., 2007). in a normal tissues like brain, heart, colon, kidney, and Cytochrome P450 (CYP) system is a multigene placenta (Karlgren et al., 2005). Recent data obtained superfamily of enzymes that play a central role in activating by RT-PCR of whole mice RNA indicate that CYP2W1 and detoxifying a wide variety of xenobiotics as well as mRNA is expressed in mouse embryos but not in adult endobiotics (Nebert, 1991). Cytochrome P450s have been animals (Huang et al., 1998), suggesting a role for proposed to be of importance both in carcinogenesis, CYP2W1 in fetal life. CYP2W1 mRNA was here found by activating precarcinogens, and as determinants to be expressed in rat fetal tissues, especially in colon of cancer chemotherapy, where they participate in but also in lung where the expression increased by fetal activation or inactivation of anti-cancer drugs (Oyama age and transiently in brain at day 16. After birth, the et al., 2004; Rooseboom et al., 2004). The relevance of CYP2W1 gene gradually becomes silent in rat and mouse, P450 modulation to cancer risk, tumorigenesis, cancer and in support of such silencing also occurring in human progression and metabolizing of different anticancer drugs is the fact that we found no or only very small amounts has not been well understood in humans. The expression of of CYP2W1 mRNA in all adult non-transformed tissues major P450s is polymorphic and results in the generation examined. It appears that CYP2W1 provides the most of multiple population-specific phenotypes with different specific form of cytochrome P450 for tumor expression drug metabolizing capabilities (Vaclavikova et al., 2007). hitherto found (Karlgren et al., 2005). 1Section of Research and Graduate Studies, Instituto Politécnico Nacional, 2Laboratory of Biochemistry and Molecular Biology, Escuela Médico Militar, SEDENA, 3Laboratory of Neurochemistry, Instituto Nacional de Pediatría, 4Service of Pathology, Clínica de Especialidades de la Mujer, SEDENA, México, *For correspondence: [email protected] Asian Pacific Journal of Cancer Prevention, Vol 13, 2012 2647 Bandala C et al Cytochrome P450 3A5 (CYP3A5) has been shown possible association between CYP expression patterns to play a role in the 16α-hydroxylation of estrogens in with some clinic-pathological risk factors. humans. Since 16-hydroxy-estrogen 1 (16-OHE1) is a putative breast carcinogen, knowledge of the enzymes Materials and Methods involved in its synthesis provides a basis for blocking its synthesis in vivo (Huang et al., 1998). CYP3A4 Biological Samples and CYP3A5 are both expressed in human female All samples of human mammary carcinomas and paired breast tissue, but not in all individuals (Huang et al., adjacent normal tissue without morphological signs of 1996), these results also provide a basis for selection of carcinoma were obtained from 31 BCa patients diagnosed potentially susceptible individuals. Recent study found at the Pathology Service, Clínica de Especialidades de la that expression of CYP3A4⁄5 was significantly associated Mujer, Secretaría de la Defensa Nacional (SEDENA) in with lymph node metastases in BCa (Murray et al., 2010). Mexico City. Normal tissues of the mammary gland were Cytochrome P450 4F11 (CYP4F11) showed catalytic obtained for reduction of mammary gland in the Service activity against endogenous eicosanoids (leukotriene of Plastic Surgery, Hospital Central Militar (SEDENA). B4) arachidonic acid, prostaglandins and lipoxins, and Tissue samples were collected during surgery and frozen hydroxyeicosatetraenoic acids and commonly used drugs at -80°C. The histological classification of the carcinomas, (erythromycin, benzphetamine, and chlorpromazine) as well as the evaluation of non-tumor breast lesions, were (Kalsotra et al., 2004; Choudhary et al., 2005). CYP4F11 made according to standard diagnostic procedures and is thought to be primarily involved in the metabolism of confirm by four pathologists. Non tumor samples were fatty acids (3-hydroxypalmitate) and arachidonic acid without morphologically detected tumor cells. Patients metabolites (Dhar et al., 2008; Uno et al., 2011). mRNA were asked to read and sign an Informed Consent in is mostly found in liver and kidney; minor expression was agreement with requirements of the Ethical Commission noted in skeletal muscle, placenta, and heart (Cui et al., of the National Institute of Public Health in México. This 2000). project has the approval of Hospital Research Ethical Cytochrome P450 8A1 (CYP8A1; Prostacyclin I2 commission (ref. no. SI-378). synthase; PGIS) gene encodes for an enzyme that acts as an isomerase and rearranges PGH2 to PGI2. PGIS Isolation of total RNA from human tumor and its adjacent is considered to be an atypical CYP because it does not normal tissues possess oxygenase activity (Ullrich et al., 1981; Smith et Approximately 100 mg of human tumor, adjacent al., 1995). PGI2 has many important biological functions. normal tissue and mammary normal tissues were separated It is the most important endogenous inhibitor of platelet and homogenized individually in a Trizol reagent (TRI aggregation discovered to date, and also causes vascular Reagent® Solution, RNA/DNA/Protein Isolation Reagent, relaxation (Moncada et al., 1976; Cathcart et al., 2010). Ambion). Total cellular RNA was extracted according PGI2 is also anti-mitogenic and inhibits DNA synthesis in to the manufacture’s protocol. The concentration of smooth muscle cells (Libby et al., 1988). The presence of total RNA in each sample was measured by Nanodrop PGIS at the nuclear and endoplasmic reticular membrane Spectrophotometer (Delaware, USA) using the ratio of suggests multiple signaling pathways for this enzyme via 260-nm/280-nm. The quality of the isolated RNA was PGI2 generation, involving both cell surface and nuclear accessed based on the integrity of the 28S, 18S, and 5S receptors. However, the cellular signaling initiated by bands after ethidium bromide staining electrophoresis of this class of compounds is probably the least understood a 1% formaldehyde denaturating gel and visualized under of all the primary prostanoids (Bos et al., 2004; Cathcart a UV transilluminator (EDAS 290 KODAK, New Haven, et al., 2010). A number of studies have demonstrated CT). Total RNA (1 μg) was successively supplemented that the prostanoid biosynthesis profile of malignant with 0.5 µL RNase inhibitor (Boehringer Mannheim cells is different compared to normal tissues (Wang and Gmbh Germany). All extracted RNAs were stored at Chen, 1996; Yokoyama et al., 1996). CYP8A1 signaling -80°C. through arachidonic acid metabolism affects a number of tumor cell survival pathways including cell proliferation Quantitative real-time PCR assays and apoptosis as well as, tumor cell invasion, metastasis Specific oligonucleotides of the CYP2W1, CYP3A5, and angiogenesis. PGI2 is a potent antimitogenic and CYP4F11 and CYP8A1 genes and for the reference
Load more

Recommended publications
  • Identification and Developmental Expression of the Full Complement Of
    Goldstone et al. BMC Genomics 2010, 11:643 http://www.biomedcentral.com/1471-2164/11/643 RESEARCH ARTICLE Open Access Identification and developmental expression of the full complement of Cytochrome P450 genes in Zebrafish Jared V Goldstone1, Andrew G McArthur2, Akira Kubota1, Juliano Zanette1,3, Thiago Parente1,4, Maria E Jönsson1,5, David R Nelson6, John J Stegeman1* Abstract Background: Increasing use of zebrafish in drug discovery and mechanistic toxicology demands knowledge of cytochrome P450 (CYP) gene regulation and function. CYP enzymes catalyze oxidative transformation leading to activation or inactivation of many endogenous and exogenous chemicals, with consequences for normal physiology and disease processes. Many CYPs potentially have roles in developmental specification, and many chemicals that cause developmental abnormalities are substrates for CYPs. Here we identify and annotate the full suite of CYP genes in zebrafish, compare these to the human CYP gene complement, and determine the expression of CYP genes during normal development. Results: Zebrafish have a total of 94 CYP genes, distributed among 18 gene families found also in mammals. There are 32 genes in CYP families 5 to 51, most of which are direct orthologs of human CYPs that are involved in endogenous functions including synthesis or inactivation of regulatory molecules. The high degree of sequence similarity suggests conservation of enzyme activities for these CYPs, confirmed in reports for some steroidogenic enzymes (e.g. CYP19, aromatase; CYP11A, P450scc; CYP17, steroid 17a-hydroxylase), and the CYP26 retinoic acid hydroxylases. Complexity is much greater in gene families 1, 2, and 3, which include CYPs prominent in metabolism of drugs and pollutants, as well as of endogenous substrates.
    [Show full text]
  • Methylation Status of Vitamin D Receptor Gene Promoter in Adrenocortical Carcinoma
    UNIVERSITÀ DEGLI STUDI DI PADOVA DEPARTMENT OF CARDIAC, THORACIC AND VASCULAR SCIENCES Ph.D Course Medical Clinical and Experimental Sciences Curriculum Clinical Methodology, Endocrinological, Diabetological and Nephrological Sciences XXIX° SERIES METHYLATION STATUS OF VITAMIN D RECEPTOR GENE PROMOTER IN ADRENOCORTICAL CARCINOMA Coordinator: Ch.mo Prof. Annalisa Angelini Supervisor: Ch.mo Prof. Francesco Fallo Ph.D Student: Andrea Rebellato TABLE OF CONTENTS SUMMARY 3 INTRODUCTION 4 PART 1: ADRENOCORTICAL CARCINOMA 4 1.1 EPIDEMIOLOGY 4 1.2 GENETIC PREDISPOSITION 4 1.3 CLINICAL PRESENTATION 6 1.4 DIAGNOSTIC WORK-UP 7 1.4.1 Biochemistry 7 1.4.2 Imaging 9 1.5 STAGING 10 1.6 PATHOLOGY 11 1.7 MOLECULAR PATHOLOGY 14 1.7.1 DNA content 15 1.7.2 Chromosomal aberrations 15 1.7.3 Differential gene expression 16 1.7.4 DNA methylation 17 1.7.5 microRNAs 18 1.7.6 Gene mutations 19 1.8 PATHOPHYSIOLOGY OF MOLECULAR SIGNALLING 21 PATHWAYS 1.8.1 IGF-mTOR pathway 21 1.8.2 WNTsignalling pathway 22 1.8.3 Vascular endothelial growth factor 23 1.9 THERAPY 24 1.9.1 Surgery 24 1.9.2 Adjuvant Therapy 27 1.9.2.1 Mitotane 27 1.9.2.2 Cytotoxic chemotherapy 30 1.9.2.3 Targeted therapy 31 1.9.2.4 Therapy for hormone excess 31 1.9.2.5 Radiation therapy 32 1.9.2.6 Other local therapies 32 1.10 PROGNOSTIC FACTORS AND PREDICTIVE MARKERS 32 PART 2: VITAMIN D 35 2.1 VITAMIN D AND ITS BIOACTIVATION 35 2.2 THE VITAMIN D RECEPTOR 37 2.3 GENOMIC MECHANISM OF 1,25(OH)2D3-VDR COMPLEX 38 2.4 CLASSICAL ROLES OF VITAMIN D 40 2.4.1 Intestine 40 2.4.2 Kidney 41 2.4.3 Bone 41 2.5 PLEIOTROPIC
    [Show full text]
  • Cytochrome P450 Enzymes in Oxygenation of Prostaglandin Endoperoxides and Arachidonic Acid
    Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 231 _____________________________ _____________________________ Cytochrome P450 Enzymes in Oxygenation of Prostaglandin Endoperoxides and Arachidonic Acid Cloning, Expression and Catalytic Properties of CYP4F8 and CYP4F21 BY JOHAN BYLUND ACTA UNIVERSITATIS UPSALIENSIS UPPSALA 2000 Dissertation for the Degree of Doctor of Philosophy (Faculty of Pharmacy) in Pharmaceutical Pharmacology presented at Uppsala University in 2000 ABSTRACT Bylund, J. 2000. Cytochrome P450 Enzymes in Oxygenation of Prostaglandin Endoperoxides and Arachidonic Acid: Cloning, Expression and Catalytic Properties of CYP4F8 and CYP4F21. Acta Universitatis Upsaliensis. Comprehensive Summaries of Uppsala Dissertations from Faculty of Pharmacy 231 50 pp. Uppsala. ISBN 91-554-4784-8. Cytochrome P450 (P450 or CYP) is an enzyme system involved in the oxygenation of a wide range of endogenous compounds as well as foreign chemicals and drugs. This thesis describes investigations of P450-catalyzed oxygenation of prostaglandins, linoleic and arachidonic acids. The formation of bisallylic hydroxy metabolites of linoleic and arachidonic acids was studied with human recombinant P450s and with human liver microsomes. Several P450 enzymes catalyzed the formation of bisallylic hydroxy metabolites. Inhibition studies and stereochemical analysis of metabolites suggest that the enzyme CYP1A2 may contribute to the biosynthesis of bisallylic hydroxy fatty acid metabolites in adult human liver microsomes. 19R-Hydroxy-PGE and 20-hydroxy-PGE are major components of human and ovine semen, respectively. They are formed in the seminal vesicles, but the mechanism of their biosynthesis is unknown. Reverse transcription-polymerase chain reaction using degenerate primers for mammalian CYP4 family genes, revealed expression of two novel P450 genes in human and ovine seminal vesicles.
    [Show full text]
  • Transcriptomic Characterization of Fibrolamellar Hepatocellular
    Transcriptomic characterization of fibrolamellar PNAS PLUS hepatocellular carcinoma Elana P. Simona, Catherine A. Freijeb, Benjamin A. Farbera,c, Gadi Lalazara, David G. Darcya,c, Joshua N. Honeymana,c, Rachel Chiaroni-Clarkea, Brian D. Dilld, Henrik Molinad, Umesh K. Bhanote, Michael P. La Quagliac, Brad R. Rosenbergb,f, and Sanford M. Simona,1 aLaboratory of Cellular Biophysics, The Rockefeller University, New York, NY 10065; bPresidential Fellows Laboratory, The Rockefeller University, New York, NY 10065; cDivision of Pediatric Surgery, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065; dProteomics Resource Center, The Rockefeller University, New York, NY 10065; ePathology Core Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065; and fJohn C. Whitehead Presidential Fellows Program, The Rockefeller University, New York, NY 10065 Edited by Susan S. Taylor, University of California, San Diego, La Jolla, CA, and approved September 22, 2015 (received for review December 29, 2014) Fibrolamellar hepatocellular carcinoma (FLHCC) tumors all carry a exon of DNAJB1 and all but the first exon of PRKACA. This deletion of ∼400 kb in chromosome 19, resulting in a fusion of the produced a chimeric RNA transcript and a translated chimeric genes for the heat shock protein, DNAJ (Hsp40) homolog, subfam- protein that retains the full catalytic activity of wild-type PKA. ily B, member 1, DNAJB1, and the catalytic subunit of protein ki- This chimeric protein was found in 15 of 15 FLHCC patients nase A, PRKACA. The resulting chimeric transcript produces a (21) in the absence of any other recurrent mutations in the DNA fusion protein that retains kinase activity.
    [Show full text]
  • Synonymous Single Nucleotide Polymorphisms in Human Cytochrome
    DMD Fast Forward. Published on February 9, 2009 as doi:10.1124/dmd.108.026047 DMD #26047 TITLE PAGE: A BIOINFORMATICS APPROACH FOR THE PHENOTYPE PREDICTION OF NON- SYNONYMOUS SINGLE NUCLEOTIDE POLYMORPHISMS IN HUMAN CYTOCHROME P450S LIN-LIN WANG, YONG LI, SHU-FENG ZHOU Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing 100191, P. R. China (LL Wang & Y Li) Discipline of Chinese Medicine, School of Health Sciences, RMIT University, Bundoora, Victoria 3083, Australia (LL Wang & SF Zhou). 1 Copyright 2009 by the American Society for Pharmacology and Experimental Therapeutics. DMD #26047 RUNNING TITLE PAGE: a) Running title: Prediction of phenotype of human CYPs. b) Author for correspondence: A/Prof. Shu-Feng Zhou, MD, PhD Discipline of Chinese Medicine, School of Health Sciences, RMIT University, WHO Collaborating Center for Traditional Medicine, Bundoora, Victoria 3083, Australia. Tel: + 61 3 9925 7794; fax: +61 3 9925 7178. Email: [email protected] c) Number of text pages: 21 Number of tables: 10 Number of figures: 2 Number of references: 40 Number of words in Abstract: 249 Number of words in Introduction: 749 Number of words in Discussion: 1459 d) Non-standard abbreviations: CYP, cytochrome P450; nsSNP, non-synonymous single nucleotide polymorphism. 2 DMD #26047 ABSTRACT Non-synonymous single nucleotide polymorphisms (nsSNPs) in coding regions that can lead to amino acid changes may cause alteration of protein function and account for susceptivity to disease. Identification of deleterious nsSNPs from tolerant nsSNPs is important for characterizing the genetic basis of human disease, assessing individual susceptibility to disease, understanding the pathogenesis of disease, identifying molecular targets for drug treatment and conducting individualized pharmacotherapy.
    [Show full text]
  • Colorectal Cancer and Omega Hydroxylases
    1 The differential expression of omega-3 and omega-6 fatty acid metabolising enzymes in colorectal cancer and its prognostic significance Abdo Alnabulsi1,2, Rebecca Swan1, Beatriz Cash2, Ayham Alnabulsi2, Graeme I Murray1 1Pathology, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, AB25, 2ZD, UK. 2Vertebrate Antibodies, Zoology Building, Tillydrone Avenue, Aberdeen, AB24 2TZ, UK. Address correspondence to: Professor Graeme I Murray Email [email protected] Phone: +44(0)1224 553794 Fax: +44(0)1224 663002 Running title: omega hydroxylases and colorectal cancer 2 Abstract Background: Colorectal cancer is a common malignancy and one of the leading causes of cancer related deaths. The metabolism of omega fatty acids has been implicated in tumour growth and metastasis. Methods: This study has characterised the expression of omega fatty acid metabolising enzymes CYP4A11, CYP4F11, CYP4V2 and CYP4Z1 using monoclonal antibodies we have developed. Immunohistochemistry was performed on a tissue microarray containing 650 primary colorectal cancers, 285 lymph node metastasis and 50 normal colonic mucosa. Results: The differential expression of CYP4A11 and CYP4F11 showed a strong association with survival in both the whole patient cohort (HR=1.203, 95% CI=1.092-1.324, χ2=14.968, p=0.001) and in mismatch repair proficient tumours (HR=1.276, 95% CI=1.095-1.488, χ2=9.988, p=0.007). Multivariate analysis revealed that the differential expression of CYP4A11 and CYP4F11 was independently prognostic in both the whole patient cohort (p = 0.019) and in mismatch repair proficient tumours (p=0.046). Conclusions: A significant and independent association has been identified between overall survival and the differential expression of CYP4A11 and CYP4F11 in the whole patient cohort and in mismatch repair proficient tumours.
    [Show full text]
  • I Copyright® Ariel R. Topletz, 2013
    Copyright® Ariel R. Topletz, 2013 i The Relative Importance of CYP26A1 and CYP26B1 in Mediating Retinoid Homeostasis: Studies on the Formation, Elimination and Biological Activity of All-trans-Retinoic Acid Metabolites Ariel R. Topletz A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington 2013 Reading Committee: Nina Isoherranen, Chair Jashvant D Unadkat Joanne Wang Program Authorized to Offer Degree: Department of Pharmaceutics ii University of Washington Abstract Ariel R. Topletz Chair of the Supervisory Committee: Associate Professor Nina Isoherranen Department of Pharmaceutics All-trans-retinoic acid (atRA), the active metabolite of Vitamin A (retinol), is an essential nutrient during both fetal development and adult life. The concentration of atRA within a cell is tightly regulated by the synthesis and elimination of atRA. One of the major elimination pathways for atRA is oxidation, predominantly by the cytochrome P450s CYP26A1 and CYP26B1 that efficiently hydroxylate atRA. The role of both CYP26A1 and CYP26B1 is believed to be to inactivate atRA, and both are essential for correct fetal development. It is not known whether both enzymes play crucial roles during adult life. In this work, the differences in the catalytic efficiency of CYP26A1 and CYP26B1 and the metabolites formed from atRA by CYP26A1 and CYP26B1 were explored. The subsequent metabolism and the activity of atRA metabolites were also evaluated. CYP26A1 was determined to form 4-OH-RA from atRA more efficiently (Km = 50 nM, Clint = 190 µL/min/pmoles P450) than CYP26B1 (Km = 19 nM, Clint = 43 µL/min/pmoles P450). In addition, formation of 4-OH-RA by CYP26A1 was stereoselective resulting in formation of (4S)-OH-RA whereas no significant stereoselectivity in 4-OH-RA formation by CYP26B1was observed.
    [Show full text]
  • The Transcriptomic Landscape of Prostate Cancer Development and Progression: an Integrative Analysis
    cancers Article The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis Jacek Marzec 1,† , Helen Ross-Adams 1,*,† , Stefano Pirrò 1 , Jun Wang 1 , Yanan Zhu 2, Xueying Mao 2, Emanuela Gadaleta 1 , Amar S. Ahmad 3, Bernard V. North 3, Solène-Florence Kammerer-Jacquet 2, Elzbieta Stankiewicz 2, Sakunthala C. Kudahetti 2, Luis Beltran 4, Guoping Ren 5, Daniel M. Berney 2,4, Yong-Jie Lu 2 and Claude Chelala 1,6,* 1 Bioinformatics Unit, Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK; [email protected] (J.M.); [email protected] (S.P.); [email protected] (J.W.); [email protected] (E.G.) 2 Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK; [email protected] (Y.Z.); [email protected] (X.M.); solenefl[email protected] (S.-F.K.-J.); [email protected] (E.S.); [email protected] (S.C.K.); [email protected] (D.M.B.); [email protected] (Y.-J.L.) 3 Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine, Queen Mary University of London, London EC1M 6BQ, UK; [email protected] (A.S.A.); [email protected] (B.V.N.) 4 Department of Pathology, Barts Health NHS, London E1 F1R, UK; [email protected] 5 Department of Pathology, The First Affiliated Hospital, Zhejiang University Medical College, Hangzhou 310058, China; [email protected] 6 Centre for Computational Biology, Life Sciences Initiative, Queen Mary University London, London EC1M 6BQ, UK * Correspondence: [email protected] (H.R.-A.); [email protected] (C.C.) † These authors contributed equally to this work.
    [Show full text]
  • Catalytic Activities of Tumor-Specific Human Cytochrome P450 CYP2W1 Toward Endogenous Substrates S
    Supplemental material to this article can be found at: http://dmd.aspetjournals.org/content/suppl/2016/03/02/dmd.116.069633.DC1 1521-009X/44/5/771–780$25.00 http://dx.doi.org/10.1124/dmd.116.069633 DRUG METABOLISM AND DISPOSITION Drug Metab Dispos 44:771–780, May 2016 Copyright ª 2016 by The American Society for Pharmacology and Experimental Therapeutics Catalytic Activities of Tumor-Specific Human Cytochrome P450 CYP2W1 Toward Endogenous Substrates s Yan Zhao, Debin Wan, Jun Yang, Bruce D. Hammock, and Paul R. Ortiz de Montellano Department of Pharmaceutical Chemistry, University of California, San Francisco (Y.Z., P.R.O.M.) and Department of Entomology and Cancer Center, University of California, Davis, CA (D.W., J.Y., B.D.H.) Received January 25, 2015; accepted February 29, 2016 ABSTRACT CYP2W1 is a recently discovered human cytochrome P450 enzyme 4-OH all-trans retinol, and it also oxidizes retinal. The enzyme much with a distinctive tumor-specific expression pattern. We show here less efficiently oxidizes 17b-estradiol to 2-hydroxy-(17b)-estradiol and that CYP2W1 exhibits tight binding affinities for retinoids, which have farnesol to a monohydroxylated product; arachidonic acid is, at best, Downloaded from low nanomolar binding constants, and much poorer binding constants a negligible substrate. These findings indicate that CYP2W1 probably in the micromolar range for four other ligands. CYP2W1 converts all- plays an important role in localized retinoid metabolism that may be trans retinoic acid (atRA) to 4-hydroxy atRA and all-trans retinol to intimately linked to its involvement in tumor development.
    [Show full text]
  • Simulation of Physicochemical and Pharmacokinetic Properties of Vitamin D3 and Its Natural Derivatives
    pharmaceuticals Article Simulation of Physicochemical and Pharmacokinetic Properties of Vitamin D3 and Its Natural Derivatives Subrata Deb * , Anthony Allen Reeves and Suki Lafortune Department of Pharmaceutical Sciences, College of Pharmacy, Larkin University, Miami, FL 33169, USA; [email protected] (A.A.R.); [email protected] (S.L.) * Correspondence: [email protected] or [email protected]; Tel.: +1-224-310-7870 or +1-305-760-7479 Received: 9 June 2020; Accepted: 20 July 2020; Published: 23 July 2020 Abstract: Vitamin D3 is an endogenous fat-soluble secosteroid, either biosynthesized in human skin or absorbed from diet and health supplements. Multiple hydroxylation reactions in several tissues including liver and small intestine produce different forms of vitamin D3. Low serum vitamin D levels is a global problem which may origin from differential absorption following supplementation. The objective of the present study was to estimate the physicochemical properties, metabolism, transport and pharmacokinetic behavior of vitamin D3 derivatives following oral ingestion. GastroPlus software, which is an in silico mechanistically-constructed simulation tool, was used to simulate the physicochemical and pharmacokinetic behavior for twelve vitamin D3 derivatives. The Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) Predictor and PKPlus modules were employed to derive the relevant parameters from the structural features of the compounds. The majority of the vitamin D3 derivatives are lipophilic (log P values > 5) with poor water solubility which are reflected in the poor predicted bioavailability. The fraction absorbed values for the vitamin D3 derivatives were low except for calcitroic acid, 1,23S,25-trihydroxy-24-oxo-vitamin D3, and (23S,25R)-1,25-dihydroxyvitamin D3-26,23-lactone each being greater than 90% fraction absorbed.
    [Show full text]
  • A Prognostic Marker in Colon Cancer
    ANTICANCER RESEARCH 32: 3869-3874 (2012) The Expression of CYP2W1: A Prognostic Marker in Colon Cancer KRISTINA STENSTEDT1,4, MARIA HALLSTROM3, INGER JOHANSSON2, MAGNUS INGELMAN-SUNDBERG2, PETER RAGNHAMMAR3 and DAVID EDLER1,4 Departments of 1Molecular Medicine and Surgery, 2Physiology and Pharmacology, and 3Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; 4Centre for Surgical Gastroenterology, Karolinska University Hospital, Stockholm, Sweden Abstract. Aim: The enzyme Cytochrome P450 2W1 has been shown to catalytically activate compounds to (CYP2W1) is found in fetal colon tissue and is also detected cytotoxic products, the enzyme might be used as a novel drug in colorectal cancer but not in non-transformed tissue. In a target for the treatment of colon cancer. pilot study, we reported that the immunohistochemically- detected expression of CYP2W1 might be of prognostic value P450 cytochromes (CYPs) belong to a superfamily of heme- since high expression of CYP2W1 was indicative of a worse containing enzymes which play important roles in prognosis. The aim of this study was to validate the pilot biosynthesis and metabolism of endogenous compounds, as study’s results using a larger, independent group of patients well as in the metabolism and detoxification of various with colon cancer. Materials and Methods: exogenous compounds, such as drugs, carcinogens and toxic Immunohistochemical detection of CYP2W1 in 235 environmental agents. Pro-carcinogens can also be activated malignant colon tumors of stage II and III, was carried out to carcinogens by CYPs. using a polyclonal antibody. Grading of staining was carried There are 57 CYP isoenzymes found in humans and they out by two independent readers. The highest grade that are arranged into subgroups based on their similarities in involved more than 5% of the tumor area on each slide was amino acid sequences.
    [Show full text]
  • MOL #76356 1 an Inducible Cytochrome P450 3A4-Dependent
    Molecular Pharmacology Fast Forward. Published on December 28, 2011 as DOI: 10.1124/mol.111.076356 Molecular PharmacologyThis article Fast has not Forward. been copyedited Published and formatted. on TheDecember final version 28, may 2011 differ asfrom doi:10.1124/mol.111.076356 this version. MOL #76356 An Inducible Cytochrome P450 3A4-dependent Vitamin D Catabolic Pathway Zhican Wang, Yvonne S. Lin, Xi Emily Zheng, Tauri Senn, Takanori Hashizume, Michele Scian, Leslie J. Dickmann, Sidney D. Nelson, Thomas A. Baillie, Mary F. Hebert, David Blough, Downloaded from Connie L. Davis, Kenneth E. Thummel molpharm.aspetjournals.org Departments of Pharmaceutics (Z.W, Y.S.L., X.E.Z., T.S., K.E.T.), Medicinal Chemistry (M.S., at ASPET Journals on September 24, 2021 S.D.N, T.A.B.), Pharmacy (M.F.H., D.B.), and Division of Nephrology (C.L.D.), University of Washington, Seattle, WA, USA; Pharmacokinetics Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd, Japan (T.H.); Biochemistry and Biophysics Group, Department of Pharmacokinetics and Drug Metabolism, Amgen, Seattle, WA, USA (L.J.D). 1 Copyright 2011 by the American Society for Pharmacology and Experimental Therapeutics. Molecular Pharmacology Fast Forward. Published on December 28, 2011 as DOI: 10.1124/mol.111.076356 This article has not been copyedited and formatted. The final version may differ from this version. MOL #76356 Running Title Page Running title: Metabolism of 25-hydroxyvitamin D3 by CYP3A4 Corresponding author: Kenneth Thummel, Ph.D. Department of Pharmaceutics, Box 357610
    [Show full text]